Combining Ketamine and Deep TMS: A New Frontier in Treating Depression
Emerging evidence suggests that combining these interventions may enhance treatment outcomes and provide options for…
Combining Ketamine and Deep TMS: A New Frontier in Treating Depression
Emerging evidence suggests that combining these interventions may enhance treatment outcomes and provide options for patients who have not responded to traditional therapies. The post Combining Ketamine and Deep TMS: A New Frontier in Treating Depression appeared first on MedCity News.
The Top 5 Most Affordable Functional Medicine Labs in Texas
[Sponsored] Functional medicine services can transform lives. Compare the best value functional health labs in Texas to discover nearby options that could fit your budget. The post The Top 5 Most Affordable Functional Medicine Labs in Texas appeared first on MedCity News.
Health Insurance Enrollment: Winning OEP With a Tech-Driven Call Center
Adding more agents or buying more leads are just pieces of the puzzle, but they don’t address the multifaceted challenge of open enrollment. Teams must be aligned around meaningful metrics rather than vanity measures like total dials. The post Health Insurance Enrollment: Winning OEP With a Tech-Driven Call Center appeared first on MedCity News.
Readers Take Congress to Task and Offer Their Own Health Policy Fixes
Letters to the Editor is a periodic feature. We welcome all comments and will publish a selection. We edit for length and clarity and require full names. Health Care as a Human Right If there is anything to take away from my over half a century of professional experience at the crossroads of law, medicine, and health care…
What the Air You Breathe May Be Doing to Your Brain
For years, the two patients had come to the Penn Memory Center at the University of Pennsylvania, where doctors and researchers follow people with cognitive impairment as they age, as well as a group with normal cognition. Both patients, a man and a woman, had agreed to donate their brains after they died for further…
An Arm and a Leg: A Few Good Things From 2025 (Really)
Massive cuts to medical research and Medicaid. Waves of layoffs across the Department of Health and Human Services. Ongoing uncertainty around federal subsidies to buy health insurance on Affordable Care Act marketplaces. 2025 has been a rough year for federal health programs. But meanwhile, in the states, there were some wins for health care access….
Lo que el aire que respiras le puede estar haciendo a tu cerebro
Durante años, dos pacientes fueron al Centro de Memoria Penn de la Universidad de Pennsylvania, donde investigadores y médicos hacen el seguimiento de personas con deterioro cognitivo a medida que envejecen y, a la vez, de un grupo con capacidad cognitiva normal. Ambos pacientes, un hombre y una mujer, habían aceptado donar sus cerebros a…
What Are the Biggest Mistakes Employers Make When Introducing Digital Mental Health Solutions?
At the Behavioral Health Tech conference, panelists said employers often rush to adopt digital mental health tools without tailoring them to employee needs or effectively promoting their use. The post What Are the Biggest Mistakes Employers Make When Introducing Digital Mental Health Solutions? appeared first on MedCity News.
DiMe, 20+ Partners Launch New Effort to Help Older Adults Age in Place
The Digital Medicine Society launched a new initiative — it seeks to establish a roadmap for how technology can support older adults who want to age safely at home. The project will bring together health systems, home health agencies and tech companies to develop products, policy guidance and case studies for scalable home care. The…
Neurocrine Bio Drug Licensed From Takeda Flunks Mid-Stage Test in Depression
The Phase 2 failure in major depressive disorder marks the second time in a little more than a year that Neurocrine Biosciences has reported a drug licensed from Takeda Pharmaceutical fell short in the clinic. Last year, a different drug from this partnership failed a mid-stage test in schizophrenia. The post Neurocrine Bio Drug Licensed…
